Fluorine-18-labeled [Nle4,D-Phe7]-α-MSH, an α-melanocyte stimulating hormone analogue

Nuclear Medicine and Biology

Volumn 24, Issue 2, 1997, Pages 171-178

  Vaidyanathan, G ^a   Zalutsky, M R ^a  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Fluorine 18; Melanocyte; MSH; Specific activity

Indexed keywords

FLUORINE 18; INTERMEDIN DERIVATIVE;

ANIMAL CELL; ARTICLE; CONTROLLED STUDY; DRUG SYNTHESIS; INTRAVENOUS DRUG ADMINISTRATION; ISOTOPE LABELING; MELANOCYTE; MELANOMA CELL; MOUSE;

EID: 0030975428     PISSN: 09698051     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0969-8051(96)00211-9     Document Type: Article

References (39)

1. C.J. Anderson T.S. Pajeau W.B. Edwards E.L. Sherman B.E. Rogers M.J. Welch In vitro and in vivo evaluation of copper-64-octreotide conjugates J. Nucl. Med. 36 1995 2315 2325
2. J.W. Babich W. Graham S. Barrow S.C. Dragotakes R.G. Tompkins R.H. Rubin A.J. Fischman Technetium-99mlabeled chemotactic peptides: Comparison with indium-111-labeled white blood cells for localizing acute bacterial infection in the rabbit J. Nucl. Med. 34 1993 2176 2181
3. 111In]-DTPA-labeled analogues of α-melanocyte-stimulating hormones for melanoma targeting: Receptor binding in vitro and in vivo Int. J. Cancer 58 1994 749 755
4. D.R. Bard C.G. Knight D.P. Page-Thomas A chelating derivative of α-melanocyte stimulating hormone as a potential imaging agent for malignant melanoma Br. J. Cancer 62 1990 919 922
5. W.A. Breeman D.J. Kwekkeboom P.P. Kooij W.H. Bakker L.J. Hofland T.J. Visser G.J. Ensing S.W. Lamberts E.P. Krenning Effect of dose and specific activity on tissue distribution of indium-111-pentetreotide in rats J. Nucl. Med. 36 1995 623 627
6. J.A. Carrasquillo Radioimmunoscintigraphy with polyclonal or monoclonal antibodies M.R. Zalutsky Antibodies in Rodiodiagnosis and Therapy 1989 CRC Press Boca Raton, FL 169 198
7. S. Carrel R.S. Accolla A.L. Carmagnola J.-P. Mach Common human melanoma-associated antigen(s) detected by monoclonal antibodies Cancer Res. 40 1980 2523 2528
8. V. Chhajlani J.E.S. Wikberg Molecular cloning and expression of the human melanocyte stimulating hormone receptor cDNA FEBS Lett. 309 1992 417 420
9. 125I-labeled anti-Tac disulfide-stabilized Fv fragments in nude mice with interleukin 2α receptor-positive tumor xenografts Cancer Res. 55 1995 5323 5329
10. 18F]fluorodopamine for positron emission tomography studies of sympathetic nervous tissue J. Med. Chem. 34 1991 861 863
11. A.N. Eberle The Melanotropins: Chemistry, Physiology and Mechanisms of Action 1988 Karger Basel 1 409
12. A.N. Eberle V.J. Verin F. Solca W. Siegrist C. Küenlin C. Bagutti S. Stutz J. Girard Biologically active monoiodinated α-MSH derivatives for receptor binding studies using human melanoma cells J. Receptor Res. 11 1991 311 322
13. A.J. Fischman D. Rauh H. Solomon J.W. Babich R.G. Tompkins D. Kroon W.H. Strauss R.H. Rubin In vivo bioactivity and biodistribution of chemotactic peptide analogs in nonhuman primates J. Nucl. Med. 34 1993 2130 2134
14. 2 fragment in a subcutaneous xenograft model Cancer Res. 52 1992 5054 5060
15. P.K. Garg K.L. Alston P.C. Welsh M.R. Zalutsky Enhanced binding and inertness to dehalogenation of α-melanotropic peptides labeled using N -succinimidyl 3-iodobenzoate Bioconjugate Chem. 7 1996 233 239
16. 1-octreotide, a potential radiopharmaceutical for quantitative somatostatin receptor imaging with PET: Synthesis, radiolabeling, in vitro validation and biodistribution in mice Nucl. Med. Biol. 21 1994 819 825
17. 18F-labelled alkylating agent 2,2,2-trifluoroethyl triflate: Synthesis and specific activity J. Label. Compd. Radiopharm. 36 1995 537 547
18. D.L. Morton J.H. Wong J.M. Kirkwood R.G. Parker Malignant melanoma J.F. Holland E. Frei R.C. Bast D.W. Kufe D.L. Morton R.R. Weichselbaum Cancer Medicine 1993 Lea & Febiger Philadelphia 1793 1824
19. J.O. Olsen R.V. Pozderac G. Hinkle T. Hill T.M. O'Dorisio W.J. Schirmer E.C. Ellison M.S. O'Dorisio Somatostatin receptor imaging of neuroendocrine tumors with indium-111 pentetreotide (Octreoscan) Semin. Nucl. Med. 25 1995 251 261
20. 2 fragment in normal dogs Nucl. Med. Biol. 21 1994 911 919
21. 18F-labeled monoclonal antibody Fab fragment J. Nucl. Med. 35 1994 1506 1513
22. T.K. Sawyer P.J. Sanfilippo V.J. Hruby M.H. Engel C.B. Heward J.B. Burnett M.E. Hadley 4-Norleucine, 7-D-phenylalanine-α-melanocyte-stimulating hormone: A highly potent α-melanotropin with ultralong biological activity Proc. Natl. Acad. Sci. USA 77 1980 5754 5758
23. 18F]fluoride Appl. Radiat. Isot. 44 1993 1459 1465
24. W. Siegrist M. Oestreicher S. Stutz J. Girard A.N. Eberle Radioreceptor assay for α-MSH using mouse B16 melanoma cells J. Receptor Res. 8 1988 323 343
25. W. Siegrist F. Solca S. Stutz L. Giuffré S. Carrel J. Girard A.N. Eberle Characterization of receptors for α-melanocytestimulating hormone on human melanoma cells Cancer Res. 49 1989 6352 6358
26. W. Siegrist A.N. Eberle Homologous regulation of the MSH receptor in melanoma cells J. Receptor Res. 13 1993 263 281
27. P.M. Smith-Jones B. Stolz C. Bruns R. Albert H.W. Reist R. Fridrich H.R. Macke Gallium-67/gallium-68-[DFO]-octreotide—a potential radiopharmaceutical for PET imaging of somatostatin receptor-positive tumors: Synthesis and radiolabeling in vitro and preliminary in vivo studies J. Nucl. Med. 35 1994 317 325
28. F. Solca W. Siegrist R. Drozdz J. Girard A.N. Eberle The receptor for α-melanotropin of mouse and human melanoma cells J. Biol. Chem. 264 1989 14277 14281
29. J.B. Tatro M.L. Entwistle B.R. Lester S. Reichlin Melanotropic receptors of murine melanoma characterized in cultured cells and demonstrated in experimental tumors in situ Cancer Res. 50 1990 1237 1242
30. M. Titeler Receptot binding theory and methodology M. Williams R.A. Glennon P.B.M.W.M. Timmermans Receptor Pharmacology and Function 1989 Marcel Dekker New York 17 45
31. G. Vaidyanathan D.D. Bigner M.R. Zalutsky Fluorine-18-labeled monoclonal antibody fragments: A potential approach for combining radioimmunoscintigraphy and positron emission tomography J. Nucl. Med. 33 1992 1535 1541
32. 18F] fluorobenzoate Nucl. Med. Biol. 19 1992 275 281
33. 18F] fluorobenzoate and its application to label an antibody fragment Bioconjugate Chem. 5 1994 352 356
34. G. Vaidyanathan M.R. Zalutsky Fluorine-18 labeled chemotactic peptides: A potential approach for the PET imaging of bacterial infections Nucl. Med. Biol. 22 1995 759 764
35. I. Virgolini A. Kurtaran M. Raderer M. Leimer P. Angelberger E. Havlik S. Li W. Scheithauer B. Niederle P. Valent H.-G. Eichler Vasoactive intestinal peptide receptor scintigraphy J. Nucl. Med. 36 1995 1732 1739
36. I. Virgolini M. Raderer A. Kurtaran P. Angelberger S. Banyai Q. Yang S. Li M. Banyai J. Pidlich B. Niederle W. Scheithauer P. Valent Vasoactive intestinal peptide-receptor imaging for the localization of intestinal adenocarcinomas and endocrine tumors N. Engl. J. Med. 331 1994 1116 1121
37. H.-J. Wester K. Hamacher G. Stöcklin A comparative study of n.c.a. fluorine-18 labeling of proteins via acylation and photochemical conjugation Nucl. Med. Biol. 23 1996 365 372
38. E.P. Wraight D.R. Bard T.S. Maughan C.G. Knight D.P. Page-Thomas The use of a chelating derivative of alpha melanocyte stimulating hormone for the clinical imaging of malignant melanoma Br. J. Radiol. 65 1992 112 118
39. M.R. Zalutsky A.S. Narula A method for the radiohalogenation of proteins resulting in decreased thyroid uptake of radioiodine Int. J. Rad. Appl. Instrum. [A] 38 1987 1051 1055